These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9653106)

  • 1. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.
    Morsy MA; Gu M; Motzel S; Zhao J; Lin J; Su Q; Allen H; Franlin L; Parks RJ; Graham FL; Kochanek S; Bett AJ; Caskey CT
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):7866-71. PubMed ID: 9653106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
    Cao H; Yang T; Li XF; Wu J; Duan C; Coates AL; Hu J
    Gene Ther; 2011 Feb; 18(2):173-81. PubMed ID: 20882053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.
    Parks RJ; Bramson JL; Wan Y; Addison CL; Graham FL
    J Virol; 1999 Oct; 73(10):8027-34. PubMed ID: 10482551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.
    Morral N; O'Neal W; Rice K; Leland M; Kaplan J; Piedra PA; Zhou H; Parks RJ; Velji R; Aguilar-Córdova E; Wadsworth S; Graham FL; Kochanek S; Carey KD; Beaudet AL
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12816-21. PubMed ID: 10536005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors.
    Everett RS; Hodges BL; Ding EY; Xu F; Serra D; Amalfitano A
    Hum Gene Ther; 2003 Dec; 14(18):1715-26. PubMed ID: 14670123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
    Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
    Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.
    Oka K; Pastore L; Kim IH; Merched A; Nomura S; Lee HJ; Merched-Sauvage M; Arden-Riley C; Lee B; Finegold M; Beaudet A; Chan L
    Circulation; 2001 Mar; 103(9):1274-81. PubMed ID: 11238273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
    Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
    Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
    Parks R; Evelegh C; Graham F
    Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helper-dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy.
    Lamartina S; Cimino M; Roscilli G; Dammassa E; Lazzaro D; Rota R; Ciliberto G; Toniatti C
    J Gene Med; 2007 Oct; 9(10):862-74. PubMed ID: 17685494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.
    Muruve DA; Cotter MJ; Zaiss AK; White LR; Liu Q; Chan T; Clark SA; Ross PJ; Meulenbroek RA; Maelandsmo GM; Parks RJ
    J Virol; 2004 Jun; 78(11):5966-72. PubMed ID: 15140994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of helper-dependent adenoviral vectors by homologous recombination.
    Toietta G; Pastore L; Cerullo V; Finegold M; Beaudet AL; Lee B
    Mol Ther; 2002 Feb; 5(2):204-10. PubMed ID: 11829528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient gene transfer and expression in islets by an adenoviral vector that lacks all viral genes.
    Guo Z; Shen J; Mital D; Hong Y; Alemany R; Zhong WW; Jensik SC; Williams JW
    Cell Transplant; 1999; 8(6):661-71. PubMed ID: 10701495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector.
    O'Neal WK; Zhou H; Morral N; Langston C; Parks RJ; Graham FL; Kochanek S; Beaudet AL
    Mol Med; 2000 Mar; 6(3):179-95. PubMed ID: 10965494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of helper-dependent adenovirus vector relies on helper virus structure and complementing.
    Zhou HS; Zhao T; Rao XM; Beaudet AL
    J Gene Med; 2002; 4(5):498-509. PubMed ID: 12221643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded-capacity adenoviral vectors--the helper-dependent vectors.
    Morsy MA; Caskey CT
    Mol Med Today; 1999 Jan; 5(1):18-24. PubMed ID: 10088128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helper-dependent adenoviral vectors in experimental gene therapy.
    Józkowicz A; Dulak J
    Acta Biochim Pol; 2005; 52(3):589-99. PubMed ID: 16082408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Van Linthout S; Lusky M; Collen D; De Geest B
    Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of immunological tolerance to adenoviral vectors by using a novel dendritic cell-based strategy.
    Kushwah R; Oliver JR; Duan R; Zhang L; Keshavjee S; Hu J
    J Virol; 2012 Apr; 86(7):3422-35. PubMed ID: 22258241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile.
    Croyle MA; Le HT; Linse KD; Cerullo V; Toietta G; Beaudet A; Pastore L
    Gene Ther; 2005 Apr; 12(7):579-87. PubMed ID: 15647765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.